ACAD

17.1102.73%
MC

Mark C. Schneyer

Executive VP & CFO

Mr. Mark C. Schneyer is Executive Vice President and Chief Financial Officer of ACADIA Pharmaceuticals Inc since December 14, 2021. He was Senior Vice President of Business Development and Chief Business Officer at ACADIA Pharmaceuticals Inc. since May 2020 until December 14, 2021 and was its Interim Chief Financial Officer since September 2021 until December 14, 2021. Mr. Schneyer is responsible for sourcing and executing business development opportunities. Mr. Schneyer joins ACADIA Pharmaceuticals Inc. from Pfizer Inc., where he was Vice President of Business Development, for the Upjohn division. Mr. Schneyer joined Pfizer’s Worldwide Business Development organization in 2011 and served in various business development positions of increasing responsibility overseeing strategic transactions spanning licensing agreements, product acquisitions and divestitures, strategic collaborations and company acquisitions. Prior to Pfizer, he was an investment banker at Lazard and advised boards of directors and senior management teams in the healthcare sector. Mr. Schneyer earned a Bachelor of Science in economics with a concentration in finance from the Wharton School of the University of Pennsylvania.

公司职务